Document is current

Any future updates will be listed below

451 Targeting a cancer cell interferon and TBK1 signaling axis to reverse acquired resistance to immune checkpoint blockade

Crossref DOI link: https://doi.org/10.1136/jitc-2025-SITC2025.0451

Published Online: 2025-11-04

Published Print: 2025-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark